JCIA
SGMO

Jackson Creek Investment Advisors’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Jackson Creek Investment Advisors’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-78,873
Closed -$1.23M – 365
2020
Q4 		$1.23M Sell
78,873
-138
-0.2% -$1.62K 0.48% 35
2020
Q3 		$747K Buy
+79,011
New +$855K 0.34% 153

Other funds holding SGMO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Jackson Creek Investment Advisors's SGMO Position: Q1 2021 in Review

Jackson Creek Investment Advisors sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q1 2021, closing a stake of 78,873 shares — an estimated $1.23M sold.

Jackson Creek Investment Advisors first reported a position in SGMO in Q3 2020 and held it in 2 quarters. The position peaked at $1.23M in Q4 2020. 203 funds tracked by Wall St. Rank hold SGMO as of Q1 2021.

  • Jackson Creek Investment Advisors reported no remaining SANGAMO THERAPEUTICS INC position as of Q1 2021 after selling out during the quarter.
  • Jackson Creek Investment Advisors sold 78,873 SANGAMO THERAPEUTICS INC shares in Q1 2021, an estimated $1.23M.
  • Jackson Creek Investment Advisors first reported a position in SANGAMO THERAPEUTICS INC in Q3 2020 and held it in 2 quarters.
  • Jackson Creek Investment Advisors's SANGAMO THERAPEUTICS INC position peaked at $1.23M in Q4 2020.
  • 203 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2021.

Based on Jackson Creek Investment Advisors's 13F filing for Q1 2021, filed 27 May 2021.